# The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal

## TL;DR

Buprenorphine can both trigger and relieve opioid withdrawal depending on when it's administered, due to its effects on opioid receptors.

## Contribution

The paper explains how buprenorphine's effects on mu-opioid receptor externalization and NOP receptor activity can cause or alleviate withdrawal.

## Key findings

- Buprenorphine promotes mu-opioid receptor externalization and resensitization, causing a signaling gap that triggers withdrawal.
- Buprenorphine relieves withdrawal once spontaneous withdrawal has begun due to its receptor activity.
- Activation of the nociceptin opioid peptide receptor may enhance buprenorphine's withdrawal-modulating effects.

## Abstract

Buprenorphine (BUP) offers a therapeutic approach for opioid use disorder (OUD) due to its unique pharmacodynamic properties, primarily as a partial agonist with high affinity for the mu‐opioid receptor (MOR). BUP's partial agonism and ceiling effect on respiratory depression enhance its safety profile. However, BUP can induce precipitated withdrawal when administered after a full agonist, leading to severe withdrawal symptoms. This Perspective builds on prior work that has linked BUP's high‐affinity partial agonism to precipitated withdrawal and low‐dose induction strategies. We focus on how BUP's capacity to promote MOR externalization, together with its activity at the nociceptin opioid peptide (NOP) receptor, can help explain why it precipitates withdrawal when administered in the presence of full agonists yet relieves withdrawal once spontaneous withdrawal has begun. Understanding these mechanisms is critical for optimizing BUP protocols in OUD treatment and informs the potential development of new biased MOR agonists (i.e., ligands that preferentially activate specific signalling pathways) for addiction therapy.

Buprenorphine can either precipitate or relieve opioid withdrawal depending on the timing of administration relative to full opioid agonist exposure. The article proposes that buprenorphine promotes mu‐opioid receptor (MOR) externalization and resensitization, creating a temporary signaling gap that explains precipitated withdrawal when full agonists are present, but withdrawal relief once spontaneous withdrawal has begun. Additional activation of the nociceptin (NOP) receptor may further contribute to its withdrawal‐modulating effects.